Adipokine Leptin mediated NOX-2 promotes kidney inflammation in nonalcoholic fatty liver disease via miR21 dependent mesangial cell immune activation

被引:0
|
作者
Alhasson, Firas A.
Das, Suvarthi
Chandrashekaran, Varun
Dattaroy, Diptadip
Seth, Ratanesh Kumar
Nagarkatti, Mitzi
Nagarkatti, Prakash
Chatterjee, Saurabh
机构
来源
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
197.16
引用
收藏
页数:4
相关论文
共 12 条
  • [1] High Circulatory Leptin Mediated NOX-2 Promotes Kidney Inflammation in Nonalcoholic Fatty Liver Disease Via MiR21-Dependent Mesangial Cell Activation
    Alhasson, Firas
    Das, Suvarthi
    Chandrashekaran, Varun
    Dattaroy, Diptadip
    Seth, Ratanesh
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Chatterjee, Saurabh
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S51 - S51
  • [2] Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21
    Albadrani, Muayad
    Seth, Ratanesh K.
    Sarkar, Sutapa
    Kimono, Diana
    Mondal, Ayan
    Bose, Dipro
    Porter, Dwayne E.
    Scott, Geoff, I
    Brooks, Bryan
    Raychoudhury, Samir
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Jule, Yvon
    Diehl, Anna Mae
    Chatterjee, Saurabh
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 317 (04): : G408 - G428
  • [3] High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease
    Alhasson, Firas
    Seth, Ratanesh Kumar
    Sarkar, Sutapa
    Kimono, Diana A.
    Albadrani, Muayad S.
    Dattaroy, Diptadip
    Chandrashekaran, Varun
    Scott, Geoffrey I.
    Raychoudhury, Samir
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Diehl, Anna Mae
    Chatterjee, Saurabh
    REDOX BIOLOGY, 2018, 17 : 1 - 15
  • [4] Microcystin exposure Exacerbates Nonalcoholic Fatty Liver Disease (NAFLD) via NOX2 Dependent Activation of miR21-induced Inflammatory Pathways
    Albadrani, Muayad
    Alhasson, Firas
    Dattaroy, Diptadip
    Chandrashekaran, Varun
    Seth, Ratanesh
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Chatterjee, Saurabh
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 61 - 61
  • [5] Microcystin exposure worsens nonalcoholic fatty liver disease associated ectopic glomerular toxicity via NOX-2-MIR21 axis
    Sarkar, Sutapa
    Alhasson, Firas
    Kimono, Diana
    Albadrani, Muayad
    Seth, Ratanesh K.
    Xiao, Shuo
    Porter, Dwayne E.
    Scott, Geoff I.
    Brooks, Bryan
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Chatterjee, Saurabh
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2020, 73
  • [6] MiR-484 promotes nonalcoholic fatty liver disease progression in mice via downregulation of Sorbs2
    Jia, Yinzhao
    Pan, Hao
    Liu, Jing
    Huang, Tiezeng
    Han, Ke
    Mei, Qiaojuan
    Zeng, Ling
    Zhou, Jinzhao
    Zhang, Yong
    OBESITY, 2023, 31 (12) : 2972 - 2985
  • [7] Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway
    Cai, Qingxian
    Chen, Fengjuan
    Xu, Fen
    Wang, Ke
    Zhang, Ka
    Li, Guojun
    Chen, Jun
    Deng, Hong
    He, Qing
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [8] Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway
    Yan, Jun-bin
    Nie, Yun-meng
    Xu, Su-mei
    Zhang, Shuo
    Chen, Zhi-yun
    PHYTOMEDICINE, 2023, 118
  • [9] Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats
    Fan, Hua
    Ma, Xiande
    Lin, Peng
    Kang, Qiang
    Zhao, Zhilong
    Wang, Lina
    Sun, Dan
    Cheng, Jiayi
    Li, Yajun
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5599 - 5612
  • [10] Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF- ?B pathway activation
    Bao, Shuyin
    Wang, Xiuzhi
    Ma, Qianqian
    Wei, Chengxi
    Nan, Jixing
    Ao, Wuliji
    CHINESE HERBAL MEDICINES, 2022, 14 (03) : 367 - 375